These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 17000688

  • 1. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
    Mutis T, van Rijn RS, Simonetti ER, Aarts-Riemens T, Emmelot ME, van Bloois L, Martens A, Verdonck LF, Ebeling SB.
    Clin Cancer Res; 2006 Sep 15; 12(18):5520-5. PubMed ID: 17000688
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quantitative assessment of human T lymphocytes in RAG2(-/-)gammac(-/-) mice: the impact of ex vivo manipulation on in vivo functionality.
    van Rijn RS, Simonetti ER, Hagenbeek A, Bonyhadi M, Storm G, Martens AC, Ebeling SB.
    Exp Hematol; 2007 Jan 15; 35(1):117-27. PubMed ID: 17198880
    [Abstract] [Full Text] [Related]

  • 4. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.
    Haematologica; 2008 Mar 15; 93(3):423-30. PubMed ID: 18287134
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J, Casaño J, Alvarez MA, Roman-Gomez J, Martin C, Martinez F, Gomez P, Serrano J, Herrera C, Torres A.
    Br J Haematol; 2004 Sep 15; 126(5):697-703. PubMed ID: 15327522
    [Abstract] [Full Text] [Related]

  • 10. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
    Wang XN, Haniffa MA, Holtick U, Collin MP, Jackson G, Hilkens CM, Holler E, Edinger M, Hoffmann P, Dickinson AM.
    Transplantation; 2009 Jul 27; 88(2):188-97. PubMed ID: 19623013
    [Abstract] [Full Text] [Related]

  • 11. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS.
    Nat Med; 2003 Sep 27; 9(9):1144-50. PubMed ID: 12925844
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.
    Ukena SN, Grosse J, Mischak-Weissinger E, Buchholz S, Stadler M, Ganser A, Franzke A.
    Ann Hematol; 2011 Feb 27; 90(2):213-8. PubMed ID: 20859740
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G.
    Transplantation; 2009 Dec 15; 88(11):1261-72. PubMed ID: 19996925
    [Abstract] [Full Text] [Related]

  • 15. The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation.
    Schneider M, Munder M, Karakhanova S, Ho AD, Goerner M.
    Clin Lab Haematol; 2006 Dec 15; 28(6):382-90. PubMed ID: 17105491
    [Abstract] [Full Text] [Related]

  • 16. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J, Fan H, Hao J, Ren Y, Chen L, Li G, Xie R, Yang Y, Qian K, Liu M.
    Transfusion; 2012 Jun 15; 52(6):1333-47. PubMed ID: 22098312
    [Abstract] [Full Text] [Related]

  • 17. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.
    Fast LD, DiLeone G, Cardarelli G, Li J, Goodrich R.
    Transfusion; 2006 Sep 15; 46(9):1553-60. PubMed ID: 16965583
    [Abstract] [Full Text] [Related]

  • 18. Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.
    Li Q, Zhai Z, Xu X, Shen Y, Zhang A, Sun Z, Liu H, Geng L, Wang Y.
    Leuk Res; 2010 Sep 15; 34(9):1158-68. PubMed ID: 20409584
    [Abstract] [Full Text] [Related]

  • 19. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
    Nguyen VH, Zeiser R, Negrin RS.
    Biol Blood Marrow Transplant; 2006 Oct 15; 12(10):995-1009. PubMed ID: 17084366
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.